These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 56695

  • 41. Differential histamine release by dextran and the ionophore A23187: the actions of inhibitors.
    Garland LG, Mongar JL.
    Int Arch Allergy Appl Immunol; 1976; 50(1):27-42. PubMed ID: 52625
    [Abstract] [Full Text] [Related]

  • 42. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G, Prigent AF.
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract] [Full Text] [Related]

  • 43. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G, Prigent AF, Pacheco H.
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract] [Full Text] [Related]

  • 44. PDE4 inhibitors: new xanthine analogues.
    Montana JG, Cooper N, Dyke HJ, Gowers L, Gregory JP, Hellewell PG, Miotla J, Morris K, Naylor R, Tuladhar B, Warneck JB.
    Bioorg Med Chem Lett; 1998 Oct 20; 8(20):2925-30. PubMed ID: 9873649
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
    Sakamoto N, Terai M, Takenaka T, Maeno H.
    Biochem Pharmacol; 1978 Oct 20; 27(8):1269-74. PubMed ID: 81059
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.
    Silver PJ, Hamel LT, Perrone MH, Bentley RG, Bushover CR, Evans DB.
    Eur J Pharmacol; 1988 May 20; 150(1-2):85-94. PubMed ID: 2841146
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW, Kuo JF.
    Biochim Biophys Acta; 1976 Sep 24; 444(2):554-62. PubMed ID: 183829
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
    Stefanovich V.
    Arzneimittelforschung; 1975 May 24; 25(5):740-1. PubMed ID: 170944
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Inhibitors of adenosine 3',5'-cyclic monophosphate phosphodiesterase in Daphne genkwa Sieb. et Zucc.
    Nikaido T, Ohmoto T, Sankawa U.
    Chem Pharm Bull (Tokyo); 1987 Feb 24; 35(2):675-81. PubMed ID: 3036384
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG, Salaman P, St Georgiev V, Weinryb I.
    Biochem Pharmacol; 1979 Apr 15; 28(8):1307-12. PubMed ID: 87199
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.